USE OF DOGS IN PHARMACEUTICAL TESTING

That this House is aware that 90,000 dogs are used each year in research across the EU and US in evaluating pharmaceutical safety and efficiency, despite there being little research compiled to assess the usefulness of them being used in advancing the development of drugs for humans; notes the findings of recent indepth analysis by both the British Union for the Abolition of Vivisection and the Fund for the Replacement of Animals in Medical Experiments which clearly shows how unreliable their use is in such testing; and believes in the light of this the use of dogs in these scientific practices should cease immediately in the UK and instead a constructive dialogue be developed between stakeholders and the Government to find a more humane and acceptable way forward on these matters.